This list is an analysis based on recent market events. It's not an investment recommendation.
About
Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in Jiaxing, China, specializes in delivering sophisticated digital operational platforms specifically designed for the biopharmaceutical industry across the country. The company's core offering is TrialOS, a comprehensive digital collaboration platform that seamlessly integrates all participants throughout the drug development and research lifecycle. This ecosystem effectively links hospitals, pharmaceutical firms, external service providers, regulatory bodies, and patients, among other key industry stakeholders. Its extensive portfolio of software solutions caters to various critical aspects of clinical research and drug development. For streamlining clinical trial operations, Taimei Medical provides tools like eCooperate, which optimizes management systems and leverages big data for informed decision-making. Other related offerings include eArchives for managing master files, eCollect for electronic data capture, eCollege for training administration, eQuality for electronic audit processes, and eBalance for interactive web-based responses. Innovations such as eVisit Patient Reported Outcomes are designed to enhance patient data input and accuracy, while eTime supports project time management, and eImage facilitates medical image interpretation. Furthermore, the company supplies specialized software tailored for hospitals and Good Clinical Practice (GCP) sites. These include eTrial for managing Phase I wards, eSite and NomenCTMS for comprehensive clinical trial management at study sites, and intelligent platforms like GCP-X and Intelligent Investigator. Solutions such as eScreening assist with subject information management and deduplication, while IIT-EDC and the Investigator-Initiated Clinical Trial Management System support investigator-initiated studies and their associated data management. In the crucial domain of drug safety, the company offers robust pharmacovigilance software solutions. This includes both global and intelligent eSafety systems, alongside the SAE Manager for efficient communication and management of critical safety data during clinical trials. Complementing these, Zhejiang Taimei also develops marketing software and a variety of other digital innovation solutions.
What is Zhejiang Taimei Medical Technology. stock price today?▼
The current price of 2576.HK is HK$5.50 HKD — it has decreased by -6.62% in the past 24 hours. Watch Zhejiang Taimei Medical Technology. stock price performance more closely on the chart.
What is Zhejiang Taimei Medical Technology. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Hong Kong Exchange exchange Zhejiang Taimei Medical Technology. stocks are traded under the ticker 2576.HK.
When is the next Zhejiang Taimei Medical Technology. earnings date?▼
Zhejiang Taimei Medical Technology. is going to release the next earnings report on August 26, 2026.
What is Zhejiang Taimei Medical Technology. revenue for the last year?▼
Zhejiang Taimei Medical Technology. revenue for the last year amounts to 589.25M HKD.
What is Zhejiang Taimei Medical Technology. net income for the last year?▼
2576.HK net income for the last year is -230.7M HKD.
How many employees does Zhejiang Taimei Medical Technology. have?▼
As of August 19, 2026, the company has 681 employees.
In which sector is Zhejiang Taimei Medical Technology. located?▼
Zhejiang Taimei Medical Technology. operates in the Technology sector.
When did Zhejiang Taimei Medical Technology. complete a stock split?▼
Zhejiang Taimei Medical Technology. has not had any recent stock splits.
Where is Zhejiang Taimei Medical Technology. headquartered?▼
Zhejiang Taimei Medical Technology. is headquartered in Jiaxing, China.